Achilles Therapeutics plc
Achilles Therapeutics plc (ACHL) Revenue
Annual & quarterly revenue history · segment & region breakdown
ACHL · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsAchilles Therapeutics plc trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Achilles Therapeutics plc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Achilles Therapeutics plc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Achilles Therapeutics plc's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ACHL revenue · 4 questionsACHL's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Achilles Therapeutics plc SEC filings · GAAP · Achilles Therapeutics plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026